Co-Diagnostics Inc (CODX)

Currency in USD
0.329
+0.009(+2.81%)
Closed·
0.320-0.009(-2.71%)
·
CODX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CODX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3050.334
52 wk Range
0.2281.580
Key Statistics
Prev. Close
0.32
Open
0.317
Day's Range
0.305-0.334
52 wk Range
0.228-1.58
Volume
354.53K
Average Volume (3m)
2.27M
1-Year Change
-74.89%
Book Value / Share
1.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CODX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.000
Upside
+2,939.51%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Co-Diagnostics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Co-Diagnostics Inc Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Co-Diagnostics Inc Earnings Call Summary for Q2/2025

  • Co-Diagnostics beats Q2 EPS forecast with -$0.23 vs -$0.66 expected, despite revenue drop to $200,000 from $2.7M last year
  • Stock falls 1.23% to $0.263 in regular trading; company maintains strong liquidity with more cash than debt on balance sheet
  • Kodiak PCR platform advancing with clinical evaluations in 2025; multiple commercial launches planned for 2026
  • Company targets FDA clearance for COVID-19 test by mid-2026, focusing on US, India, and Africa markets
  • Revenue decline of 47.62% over last 12 months; analysts anticipate further sales decline this year
Last Updated: 14/08/2025, 22:22
Read Full Transcript

Compare CODX to Peers and Sector

Metrics to compare
CODX
Peers
Sector
Relationship
P/E Ratio
−0.3x−3.8x−0.6x
PEG Ratio
−0.03−0.090.00
Price/Book
0.3x3.4x2.6x
Price / LTM Sales
12.3x3.4x3.3x
Upside (Analyst Target)
-41.3%39.4%
Fair Value Upside
Unlock5.2%4.9%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 10.000
(+2,939.51% Upside)

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-0.23 / -0.66
Revenue / Forecast
200.00K / 200.00K
EPS Revisions
Last 90 days

CODX Income Statement

People Also Watch

-
OP
0.00%
-
SNGX
0.00%
-
GIBO
0.00%

FAQ

What Stock Exchange Does Co-Diagnostics Trade On?

Co-Diagnostics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Co-Diagnostics?

The stock symbol for Co-Diagnostics is "CODX."

What Is the Co-Diagnostics Market Cap?

As of today, Co-Diagnostics market cap is 12.48M.

What Is Co-Diagnostics's Earnings Per Share (TTM)?

The Co-Diagnostics EPS (TTM) is -1.14.

When Is the Next Co-Diagnostics Earnings Date?

Co-Diagnostics will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is CODX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Co-Diagnostics Stock Split?

Co-Diagnostics has split 0 times.

How Many Employees Does Co-Diagnostics Have?

Co-Diagnostics has 132 employees.

What is the current trading status of Co-Diagnostics (CODX)?

As of 04 Sept 2025, Co-Diagnostics (CODX) is trading at a price of 0.329, with a previous close of 0.32. The stock has fluctuated within a day range of 0.305 to 0.334, while its 52-week range spans from 0.228 to 1.580.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.